EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

被引：55
|
作者：
Locquet, Medea [1 ]
Beaudart, Charlotte [1 ]
Petermans, Jean [2 ]
Reginster, Jean-Yves [1 ]
Bruyere, Olivier [1 ]
机构：
[1] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspects Musculoskelet, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
[2] CHU Liege, Geriatr Dept, Liege, Belgium
来源：
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/j.jamda.2018.11.027
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [31] Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines
    Bertschi, Dominic
    Kiss, Caroline M.
    Beerli, Nadine
    Kressig, Reto W.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (04) : 653 - 660
  • [32] DISCRIMINATIVE POWER OF THE SARCOPENIA QUALITY OF LIFE (SARQOL®) QUESTIONNAIRE WITH THE EWGSOP2 CRITERIA
    Geerinck, A.
    Locquet, M.
    Reginster, J. -Y.
    Bruyere, O.
    Beaudart, C.
    JOURNAL OF FRAILTY & AGING, 2021, 10 (02): : 193 - 194
  • [33] Discriminative Power of the Sarcopenia Quality of Life (SarQoL®) Questionnaire with the EWGSOP2 Criteria
    A. Geerinck
    M. Locquet
    J.-Y. Reginster
    O. Bruyère
    C. Beaudart
    The Journal of Frailty & Aging, 2021, 10 : 193 - 194
  • [34] Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines
    Dominic Bertschi
    Caroline M. Kiss
    Nadine Beerli
    Reto W. Kressig
    European Journal of Clinical Nutrition, 2021, 75 : 653 - 660
  • [35] Prevalence and risk factors for sarcopenia in active community-dwelling older adults according to the EWGSOP2 criteria
    Polo-Ferrero, Luis
    Recio-Rodriguez, Jose I.
    Gonzalez-Manzano, Susana
    Saez-Gutierrez, Susana
    Barbero-Iglesias, Fausto J.
    Mendez-Sanchez, Roberto
    GERIATRIC NURSING, 2024, 60 : 361 - 366
  • [36] Comparison of the Prevalence and Characteristics Between EWGSOP1-and EWGSOP2-defined Sarcopenia in Patients with Colorectal Cancer
    Feng Min Zhang
    Zhen Yu
    Han Ping Shi
    Cheng Le Zhuang
    JournalofNutritionalOncology, 2020, 5 (01) : 14 - 21
  • [37] EWGSOP-2 vs. EWGSOP-1: Impact on Prevalence of Sarcopenia in Postmenopausal Women Aged 60 Years and Older - Preliminary Report
    Cons Molina, Francisco Fidencio
    Garcia Jimenez, Daniela
    Castro Maldonado, Jesus Hairam
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 276 - 276
  • [38] Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions
    Scott, David
    Blyth, Fiona
    Naganathan, Vasi
    Couteur, David G. Le
    Handelsman, David J.
    Waite, Louise M.
    Hirani, Vasant
    CLINICAL NUTRITION, 2023, 42 (09) : 1610 - 1618
  • [39] Prevalence of sarcopenia in older women and level of agreement between the diagnostic instruments proposed by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)
    Sutil, Daiana Vieira
    Parentoni, Adriana Netto
    Teixeira, Leonardo Augusto Da Costa
    Moreira, Bruno de Souza
    Leopoldino, Amanda Aparecida Oliveira
    Mendonca, Vanessa Amaral
    Lacerda, Ana Cristina Rodrigues
    Danielewicz, Ana Lucia
    de Avelar, Nubia Carelli Pereira
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [40] Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations
    Luz Sanchez-Tocino, M.
    Miranda-Serrano, Blanca
    Gracia-Iguacel, Carolina
    Maria de-Alba-Penaranda, Ana
    Mas-Fontao, Sebastian
    Lopez-Gonzalez, Antonio
    Villoria-Gonzalez, Silvia
    Pereira-Garcia, Monica
    Ortiz, Alberto
    Gonzalez-Parra, Emilio
    PLOS ONE, 2022, 17 (01):
12345